Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria.
Department of Internal Medicine III, Division of Endocrinology and Metabolism, Gender Medicine Unit, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Diabetologia. 2017 Dec;60(12):2504-2513. doi: 10.1007/s00125-017-4437-6. Epub 2017 Sep 16.
AIMS/HYPOTHESIS: Roux-en-Y gastric bypass (RYGB) surgery is characterised by glycaemic variability. Prospective studies of glucose metabolism in pregnancy after RYGB are not available, therefore this study aimed to evaluate physiological alterations in glucose metabolism in pregnancy following RYGB.
Sixty-three pregnant women (25 who underwent RYGB, 19 non-operated obese control women and 19 normal weight control women) were included. Frequently sampled 3 h OGTTs and 1 h IVGTTs were performed between 24 and 28 weeks of gestation and, in a subgroup, were repeated at 3-6 months after delivery.
We observed major alterations in glucose kinetics during the OGTT, including an early increase in plasma glucose followed by hypoglycaemia in 90% of women who had previously undergone RYGB. The higher degree of glycaemic variability in this group was accompanied by increased insulin, C-peptide and glucagon concentrations after oral glucose load, whereas no differences in insulin response were observed after parenteral glucose administration (RYGB vs normal weight). IVGTT data suggested improved insulin sensitivity (mean difference 0.226 × 10 min [pmol/l] [95% CI 0.104, 0.348]; p < 0.001) and disposition index in pregnancies after RYGB when compared with obese control women. However, subtle alterations in insulin action and beta cell function were still observed when comparing women who had undergone RYGB with the normal-weight control group. Moreover, we observed that fetal growth was associated with maternal glucose nadir levels and insulin secretion in offspring of those who had previously undergone RYGB.
CONCLUSIONS/INTERPRETATION: Pregnancies after RYGB are affected by altered postprandial glucose, insulin and C-peptide dynamics. Insulin sensitivity is improved by RYGB, although subtle alterations in beta cell function are observed. Longitudinal studies are needed to assess potential consequences for fetal development and pregnancy outcomes.
目的/假设:Roux-en-Y 胃旁路(RYGB)手术的特点是血糖变异性。RYGB 后妊娠期间葡萄糖代谢的前瞻性研究尚不可用,因此本研究旨在评估 RYGB 后妊娠期间葡萄糖代谢的生理变化。
共纳入 63 名孕妇(25 名接受 RYGB,19 名未手术肥胖对照组和 19 名正常体重对照组)。在妊娠 24-28 周时进行频繁采样 3 小时 OGTT 和 1 小时 IVGTT,并在产后 3-6 个月对亚组进行重复。
我们观察到 OGTT 期间葡萄糖动力学的重大变化,包括 90%之前接受 RYGB 的女性出现血浆葡萄糖早期升高,随后出现低血糖。该组更高的血糖变异性伴随着口服葡萄糖负荷后胰岛素、C 肽和胰高血糖素浓度的增加,而静脉葡萄糖给药后胰岛素反应没有差异(RYGB 与正常体重)。IVGTT 数据表明,与肥胖对照组相比,RYGB 后妊娠的胰岛素敏感性(平均差异 0.226×10min [pmol/l] [95%CI 0.104, 0.348];p<0.001)和处置指数有所改善。然而,当比较 RYGB 女性与正常体重对照组时,仍观察到胰岛素作用和β细胞功能的细微变化。此外,我们观察到,在之前接受 RYGB 的女性中,胎儿生长与母亲的血糖低谷水平和后代的胰岛素分泌有关。
结论/解释:RYGB 后的妊娠受到餐后血糖、胰岛素和 C 肽动力学变化的影响。RYGB 改善了胰岛素敏感性,但观察到β细胞功能的细微变化。需要进行纵向研究以评估对胎儿发育和妊娠结局的潜在影响。